China Medical News

2024

December: New Imported Drug Approvals by the NMPA - November 2024
  • □ Belzutifan Tablets (Brand; WELIREG) – marketed by MERCK SHARP & DOHME (UK) LIMITED
  • □ Varenicline Tartrate Nasal Spray (Brand; N/A) – marketed by Oyster Point Pharma, Inc.
  • □ Ambroxol Hydrochloride Spray (Brand; N/A) – marketed by GMep Medical Technology GmbH
  • □ Minocycline Hydrochloride Foam (Brand; N/A) – marketed by Journey Medical Corporation
  • □ Efgartigimod Alfa Injection (SubQ) (Brand; VYVGART HYTRULO) – marketed by argenx BV
  • □ Rilonacept for Injection (Brand; ARCALYST) – marketed by Kiniksa Pharmaceuticals (UK),Ltd.
  • □ Mirvetuximab Soravtansine Injection (Brand; ELAHERE) – marketed by ImmunoGen, Inc.
  • □ Recombinant Human Papillomavirus Quadrivalent Vaccine (Brand; GARDASIL) – marketed by Merck Sharp & Dohme LLC

 

(Source: BaiPharm)

Page Top